Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells
Heyu Chen, Yuanzhi Chen, Mi Deng, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000515-e000515
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Combination strategies to maximize the benefits of cancer immunotherapy
Shaoming Zhu, Tian Zhang, Lei Zheng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 426
Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy
Yanhui Zheng, Yaobao Han, Qiao Sun, et al.
Exploration (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 116
Targeting macrophages in hematological malignancies: recent advances and future directions
Wei Li, Fang Wang, Rongqun Guo, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 96
Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules
Ali Hazrati, Kosar Malekpour, Hossein Khorramdelazad, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Targeting the macrophage immunocheckpoint: a novel insight into solid tumor immunotherapy
Bei Zhou, Yan Yang, Yan Kang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 9
“Find Me” and “Eat Me” signals: tools to drive phagocytic processes for modulating antitumor immunity
Lingjun Xiao, Louqian Zhang, Ciliang Guo, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 791-832
Open Access | Times Cited: 8
Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
Tobias Zeller, Ira A. Münnich, Roland Windisch, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Human leukocyte immunoglobulin-like receptors in health and disease
Silvia Redondo-García, Christopher Barritt, Charys Papagregoriou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
Jiji V. D. Attia, Charlotte E. Dessens, Ricky B. van de Water, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8678-8678
Open Access | Times Cited: 40
Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer
Mi Deng, Heyu Chen, Xiaoye Liu, et al.
Antibody Therapeutics (2021) Vol. 4, Iss. 1, pp. 16-33
Open Access | Times Cited: 34
LILRB1-directed CAR-T cells for the treatment of hematological malignancies
Katsiaryna Marhelava, Klaudyna Fidyt, Monika Pępek, et al.
Leukemia (2025)
Open Access
Targeting myeloid cells for hematological malignancies: the present and future
Zhenpeng Guan, Zhengqi Zhang, Kaiyan Wang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer
Qiong-Yuan Chen, Yuxin Chen, Qiu-Yue Han, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 30
Human inhibitory leukocyte Ig-like receptors: from immunotolerance to immunotherapy
Calvin D. De Louche, Ali Roghanian
JCI Insight (2022) Vol. 7, Iss. 2
Open Access | Times Cited: 21
Harnessing natural killer cells for the treatment of multiple myeloma
Joseph Clara, Richard W. Childs
Seminars in Oncology (2022) Vol. 49, Iss. 1, pp. 69-85
Open Access | Times Cited: 21
Blocking LAIR1 signaling in immune cells inhibits tumor development
Jingjing Xie, Xun Gui, Mi Deng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
LILRB4, an immune checkpoint on myeloid cells
Ting Yang, Yixin Qian, Xiaoting Liang, et al.
Blood Science (2022) Vol. 4, Iss. 2, pp. 49-56
Open Access | Times Cited: 19
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis
Miao Xian, Qiang Wang, Liuling Xiao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Myeloid checkpoints for cancer immunotherapy
Yixin Qian, Ting Yang, Huan Liang, et al.
Chinese Journal of Cancer Research (2022) Vol. 34, Iss. 5, pp. 460-482
Open Access | Times Cited: 18
Harnessing Natural Killer Cells for Lung Cancer Therapy
Shoubao Ma, Michael A. Caligiuri, Jianhua Yu
Cancer Research (2023) Vol. 83, Iss. 20, pp. 3327-3339
Closed Access | Times Cited: 10
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development
Ryan Huang, Xiaoye Liu, Jaehyup Kim, et al.
Cancer Immunology Research (2023) Vol. 12, Iss. 3, pp. 350-362
Open Access | Times Cited: 10
Harnessing natural killer cell effector function against cancer
Matthew D. Blunt, Salim I. Khakoo
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies
Wenyue Sun, Shunfeng Hu, Xin Wang
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 1071-1097
Open Access | Times Cited: 3
Mechanisms for Host Immune Evasion Mediated by Plasmodium falciparum-Infected Erythrocyte Surface Antigens
Akihito Sakoguchi, Hisashi Arase
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top